Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 97.25
+2.60 (2.75%)
Jul 10, 2026, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 89.58 billion as of July 10, 2026. Its market cap has increased by 6.12% in one year.
Market Cap
89.58B
Enterprise Value
84.33B
Revenue
3.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
97.25
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 89.58B, an increase of 383.07%. That is a compound annual growth rate of 28.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 89.58B | -13.94% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 263.84B |
| Innovent Biologics | 155.92B |
| WuXi Biologics | 155.87B |
| Sichuan Kelun-Biotech Biopharmaceutical | 120.44B |
| Sino Biopharmaceutical | 92.53B |
| RemeGen | 72.30B |
| Biocytogen Pharmaceuticals (Beijing) | 49.47B |
| 3SBio | 45.19B |